Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK signs $196 mln U.S. anthrax treatment deal
GSK signs $196 mln U.S. anthrax treatment deal
GSK signs $196 mln U.S. anthrax treatment deal
Submitted by
admin
on September 20, 2013 - 10:21am
Source:
Reuters
News Tags:
GSK
anthrax
government contracts
raxibacumab
Headline:
GSK signs $196 mln U.S. anthrax treatment deal
Do Not Allow Advertisers to Use My Personal information
